Investigational medications in the treatment of alopecia.

Title

Investigational medications in the treatment of alopecia.

Creator

Poulos Georgann A; Mirmirani Paradi

Publisher

Expert opinion on investigational drugs

Date

2005
2005-02

Description

Androgenetic alopecia (hereditary thinning) is the most common cause of hair loss in both men and women. Chemotherapy-induced alopecia is another distressing cause of hair loss. With a better understanding of follicular biology and the signals responsible for hair growth and regression, targeted therapies for hair loss are being investigated. This review summarises investigational medications for androgenetic and chemotherapy-induced alopecia that are in preclinical stages or later.

Subject

Humans; Animals; Alopecia/chemically induced/*drug therapy/genetics; Androgen Antagonists/therapeutic use; Antineoplastic Agents/adverse effects/therapeutic use; Clinical Trials as Topic/methods; Drugs; Investigational/*therapeutic use

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

177–184

Issue

2

Volume

14

Citation

Poulos Georgann A; Mirmirani Paradi, “Investigational medications in the treatment of alopecia.,” NEOMED Bibliography Database, accessed November 29, 2022, https://neomed.omeka.net/items/show/4980.

Social Bookmarking